Search results for "Saphenous vein"

showing 10 items of 46 documents

Minimally invasive techniques in the treatment of saphenous varicose veins.

2008

Lower extremity venous insufficiency is common and increases with age. In addition to classical symptoms, it may result in skin changes and venous ulcers. Chronic venous insufficiency has a great impact on patients' health-related quality of life and is associated with considerable health care costs. Surgical ligation Of the junction with or without stripping has been the standard of care in the treatment of insufficient great and small saphenous veins. However, the recurrence rates are relatively high and surgery may be associated with serious adverse events and considerable down time; it is also cosmetically Suboptimal. To improve efficacy, patients' health-related quality of life and tre…

medicine.medical_specialtymedicine.drug_classChronic venous insufficiencyRadiofrequency ablationmedicine.medical_treatmentLow molecular weight heparinDermatologylaw.inventionVaricose VeinsQuality of lifelawVaricose veinsSclerotherapymedicineSclerotherapyHumansMinimally Invasive Surgical ProceduresSaphenous VeinAdverse effectbusiness.industryGreat saphenous veinmedicine.diseaseSurgeryCatheter AblationLaser Therapymedicine.symptombusinessJournal of the American Academy of Dermatology
researchProduct

External polytetrafluoroethylene reinforcement of varicose autologous vein grafts in peripheral bypass surgery produces durable bypass function

2017

Abstract Objective Use of autologous veins as peripheral bypass graft may become critical in the presence of significant varicose degeneration of the harvested vein. External support of such dilated veins with standard polytetrafluoroethylene (PTFE) prostheses was recommended as an option to use these veins for peripheral bypass. A single-center experience with this technique regarding long-term graft function, secondary reinterventions, and potential graft degeneration is presented. Methods Between January 1995 and January 2006, there were 54 patients with varicose veins who underwent 57 consecutive infrainguinal vein bypass operations with PTFE reinforcement in 57 limbs. Indications for s…

Malemedicine.medical_specialtyTime Factors030204 cardiovascular system & hematology030230 surgeryTransplantation AutologousVaricose VeinsPopliteal aneurysm03 medical and health sciences0302 clinical medicineGermanyVaricose veinsmedicineHumansSaphenous VeinVeinPolytetrafluoroethyleneAgedRetrospective StudiesAged 80 and overUltrasonography Doppler Duplexmedicine.diagnostic_testbusiness.industryIncidenceGraft SurvivalAngiographyGraft Occlusion VascularMiddle Agedmedicine.diseaseSurgerySurvival RateTransplantationStenosismedicine.anatomical_structureBypass surgeryAngiographyFemaleVascular GraftingSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessClaudicationFollow-Up StudiesJournal of Vascular Surgery
researchProduct

CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions

1992

Blood cells express a cell membrane protein, termed homologous restriction factor 20 (HRF20) and identical to CD59, that can inhibit complement C5b-9 insertion into their membranes. In this report, we investigated by immunohistochemistry whether CD59 was present on cells in human atherosclerotic lesions since membranous C5b-9(m) has been found in lesions. Using a monoclonal anti-CD59 antibody, a cellular CD59 staining pattern was apparent in nearly all lesion specimens. CD59 stain co-localised with macrophage (CD14), T lymphocyte (CD7), endothelial cell (anti-factor VIII related antigen) and smooth muscle cell cytoskeletal-specific antigens (anti-alpha actin and muscle myosin). Endothelial …

Pathologymedicine.medical_specialtyCell typeArteriosclerosisCD59 Antigenschemical and pharmacologic phenomenaComplement Membrane Attack ComplexMyosinsBiologyAntigenAntigens CDMyosinmedicineHumansMacrophageSaphenous VeinActinComplement Inactivator ProteinsMembrane GlycoproteinsImmunohistochemistryActinsEndothelial stem cellCarotid ArteriesCD59 antigenEndothelium VascularCardiology and Cardiovascular MedicineComplement membrane attack complexAtherosclerosis
researchProduct

The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins

2014

ObjectiveCyanoacrylate (CA) embolization of refluxing great saphenous veins (GSVs) has been previously described. The outcomes from a multicenter study are still lacking.MethodsA prospective multicenter study was conducted in seven centers in four European countries to abolish GSV reflux by endovenous CA embolization. Neither tumescent anesthesia nor postinterventional compression stockings were used. Varicose tributaries remained untreated until at least 3 months after the index treatment. Clinical examination, quality of life assessment, and duplex ultrasound evaluation were performed at 2 days and after 1, 3, 6, and 12 months.ResultsIn 70 patients, of whom 68 (97.1%) were available for 1…

medicine.medical_specialtymedicine.medical_treatmentPhysical examinationCompression stockingslaw.inventionCohort StudieslawVaricose veinsHumansMedicineSaphenous VeinCyanoacrylatesProspective StudiesEmbolizationProspective cohort studyTumescent anesthesiamedicine.diagnostic_testbusiness.industryRefluxEmbolization TherapeuticSurgeryEuropeTreatment OutcomeVenous InsufficiencyCyanoacrylateAnesthesiaQuality of LifeSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Vascular Surgery: Venous and Lymphatic Disorders
researchProduct

Popliteal Artery Aneurysm Repair in the Endovascular Era: Fourteen-Years Single Center Experience

2015

Abstract To compare outcomes of popliteal artery aneurysm (PAA) repair by endovascular treatment, great saphenous vein (GSV) bypass, and prosthetic bypass. Single center retrospective analysis of patients presenting PAA from 2000 to 2013. Patients were divided into endovascular treatment (group A); GSV bypass (group B); and prosthetic graft bypass (group C). Outcomes were technical success, perioperative mortality, and morbidity. Survival, primary and secondary patency, and freedom from reintervention rate were estimated. Differences in ankle-brachial index (ABI), in-hospital length of stay (InH-Los), red blood cell (RBC) transfusion, and limb loss were reported. Mean follow-up was 49 (medi…

Malemedicine.medical_specialtyTime Factors7100Observational Study610 Medicine & health2700 General MedicineSingle CenterSettore MED/22 - Chirurgia VascolareGroup Blaw.inventionBlood Vessel Prosthesis ImplantationAneurysmRandomized controlled triallawmedicine.arteryPopliteal Artery AneurysmmedicineHumansPopliteal ArteryAgedRetrospective Studiesbusiness.industryGreat saphenous veinEndovascular ProceduresAngiographyRetrospective cohort studyGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseAneurysmPopliteal artery10020 Clinic for Cardiac SurgerySurgeryTreatment OutcomeSurgery Computer-AssistedAnesthesiaFluoroscopyFemaleStentsbusinessFollow-Up StudiesForecastingResearch Article
researchProduct

Arginine Vasopressin Enhances Sympathetic Constriction Through the V 1 Vasopressin Receptor in Human Saphenous Vein

1998

Background —Arginine vasopressin (AVP) not only acts directly on blood vessels through V 1 receptor stimulation but also may modulate adrenergic-mediated responses in animal experiments in vivo and in vitro. The aim of the present study was to investigate whether AVP can contribute to an abnormal adrenergic constrictor response of human saphenous veins. Methods and Results —Saphenous vein rings were obtained from 32 patients undergoing coronary artery bypass surgery. The vein rings were suspended in organ bath chambers for isometric recording of tension. AVP (3×10 −9 mol/L) enhanced the contractions elicited by electrical field stimulation at 1, 2, and 4 Hz (by 80%, 70%, and 60%, respectiv…

MaleAgonistReceptors VasopressinVasopressinmedicine.medical_specialtyNifedipinemedicine.drug_classStimulationPotassium ChlorideNorepinephrine (medication)NorepinephrineCulture TechniquesPhysiology (medical)Internal medicineHumansMedicineSaphenous VeinAgedVasopressin receptorbusiness.industryMiddle AgedCalcium Channel BlockersElectric StimulationArginine VasopressinEndocrinologymedicine.anatomical_structureCirculatory systemFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessAntidiuretic Hormone Receptor AntagonistsVasoconstrictionmedicine.drugBlood vesselCirculation
researchProduct

Ultrasound in Varicose Vein Treatment

2014

Diagnosis is a prerequisite for all treatment strategies. Duplex ultrasound is the best diagnostic tool for varicose veins for all expressions of the disease (Nicolaides Circulation 102:126–163, 2000). All types of intervention on varicose veins have their own special demands on ultrasound. Ultrasound-guided vein mapping on the skin is very helpful prior to saphenous stripping (See Sect. 12.1), and it is absolutely indispensible for CHIVA (See Sect. 12.2). In endovascular thermal therapies (See Sect. 12.3) or foam sclerotherapy of trunk veins (See Sect. 12.4), ultrasound is an essential part of the treatment process. The actual procedures will only be explained here in relation to ultrasoun…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentTreatment processGreat saphenous veinUltrasoundVaricose veinscardiovascular systemmedicineSclerotherapyTreatment strategyRadiologymedicine.symptombusinessLower limbs venous ultrasonography
researchProduct

Five-year results from the prospective European multicentre cohort study on radiofrequency segmental thermal ablation for incompetent great saphenous…

2015

AbstractBackgroundThis was a prospective study of radiofrequency segmental thermal ablation (RFA) for the treatment of incompetent varicose great saphenous veins (GSVs). The present report describes long-term follow-up at 5 years.MethodsThe 5-year follow-up of this multicentre European study included assessment of the Venous Clinical Severity Score (VCSS), and GSV occlusion and reflux on duplex imaging.ResultsA total of 225 patients had 295 GSVs treated by RFA, achieving an initial vein occlusion rate of 100 per cent. With 80·0 per cent compliance, Kaplan–Meier analyses showed a GSV occlusion rate of 91·9 per cent and a reflux-free rate of 94·9 per cent at 5 years. Among the 15 GSVs noted w…

medicine.medical_specialtyHot TemperatureRadiofrequency ablationmedicine.medical_treatmentCatheter ablationlaw.inventionVaricose VeinslawVaricose veinsOcclusionmedicineHumansSaphenous VeinProspective StudiesProspective cohort studyUltrasonographybusiness.industryRefluxOriginal ArticlesVein occlusionSurgeryTreatment OutcomeVenous InsufficiencyCatheter AblationSurgerymedicine.symptombusinessCohort studyBritish Journal of Surgery
researchProduct

Relaxant and antiadrenergic effects of ranolazine in human saphenous vein.

2019

Abstract OBJECTIVES Ranolazine improves vascular function in animal models. We evaluate the effects of ranolazine on vascular function and adrenergic response in human saphenous vein. METHODS Rings from 53 patients undergoing coronary artery bypass grafting were mounted in organ baths. Concentration–response curves to ranolazine were constructed in rings precontracted with phenylephrine, endothelin-1, vasopressin, KCl and the thromboxane A2 analogue U-46619. In rings precontracted with phenylephrine, relaxation to ranolazine was tested in the absence and presence of endothelial factors inhibitors, K+ channel blockers and verapamil. The effects of ranolazine on frequency–response and concent…

Pulmonary and Respiratory MedicineAdrenergic AntagonistsCharybdotoxinAdrenergicRanolazine030204 cardiovascular system & hematologyPharmacologyNitric Oxide03 medical and health scienceschemistry.chemical_compoundPotassium Channels Calcium-Activated0302 clinical medicineRanolazineMedicineAnimalsHumansChannel blockerSaphenous Vein030212 general & internal medicinePhenylephrineTetraethylammoniumbusiness.industryGeneral MedicineNG-Nitroarginine Methyl EsterchemistryVerapamilSurgeryEndothelium Vascularmedicine.symptomCardiology and Cardiovascular MedicinebusinessVasoconstrictionmedicine.drugEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment o…

2011

BackgroundRadiofrequency segmental thermal ablation (RSTA) has become a commonly used technology for occlusion of incompetent great saphenous veins (GSVs). Midterm results and data on clinical parameters are still lacking.MethodsA prospective multicenteral trial monitored 295 RSTA-treated GSVs for 36 months. Clinical control visits included flow and reflux analysis by duplex ultrasound imaging and assessment of clinical parameters according to the CEAP classification and Venous Clinical Severity Score (VCSS).ResultsA total of 256 of 295 treated GSVs (86.4%) were available for 36 months of follow-up. At 36 months, Kaplan-Meier survival analysis showed the probability of occlusion was 92.6% a…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentmedicine.medical_treatmentPainKaplan-Meier EstimateRisk AssessmentSeverity of Illness IndexVaricose VeinsYoung AdultPredictive Value of TestsRisk FactorsOcclusionHumansPain ManagementMedicineSaphenous VeinProspective StudiesVeinProspective cohort studyAgedPain MeasurementUltrasonography Doppler DuplexChi-Square Distributionbusiness.industryVascular diseaseEndovascular ProceduresGreat saphenous veinRefluxMiddle Agedmedicine.diseaseAblationSurgeryEuropeTreatment Outcomemedicine.anatomical_structureRegional Blood FlowPredictive value of testsCatheter AblationFemaleSurgeryCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesJournal of Vascular Surgery
researchProduct